Cargando…
The increasing threat of silver-resistance in clinical isolates from wounds and burns
PURPOSE: The widespread use of silver-containing compounds has led to emergence of silver-resistant bacteria. Few studies are available on the detectability of plasmid-mediated silver-resistance in developing countries. Therefore, we aimed to detect silver-resistance in isolates from wounds and burn...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636436/ https://www.ncbi.nlm.nih.gov/pubmed/31372006 http://dx.doi.org/10.2147/IDR.S209881 |
_version_ | 1783436061582557184 |
---|---|
author | Hosny, Alaa El-Dien MS Rasmy, Salwa A Aboul-Magd, Dina S Kashef, Mona T El-Bazza, Zeinab E |
author_facet | Hosny, Alaa El-Dien MS Rasmy, Salwa A Aboul-Magd, Dina S Kashef, Mona T El-Bazza, Zeinab E |
author_sort | Hosny, Alaa El-Dien MS |
collection | PubMed |
description | PURPOSE: The widespread use of silver-containing compounds has led to emergence of silver-resistant bacteria. Few studies are available on the detectability of plasmid-mediated silver-resistance in developing countries. Therefore, we aimed to detect silver-resistance in isolates from wounds and burns, and to genetically characterize plasmid-mediated silver-resistance genes (sil genes). METHODS: One hundred and fifty clinical isolates were obtained from burns and wounds. They were identified using the suitable Analytical Profile Index and MicroScan identification systems. Their antimicrobial susceptibility was tested by the disk diffusion and broth microdilution methods. Their silver nitrate (AgNO(3)) minimum inhibitory concentration (MIC) was determined using the broth macrodilution method. The presence of different sil genes on plasmids extracted from silver-resistant isolates and the replicon types of the extracted plasmids were investigated using polymerase chain reaction (PCR). The ability of these plasmids to impart silver-resistance was tested by transformation. RESULTS: All except two isolates were multidrug-resistant. Nineteen silver-resistant bacterial isolates (12.6%) were detected; with AgNO(3) MIC ≥512 µg/mL. They were identified as Klebsiella pneumoniae (n=7), Staphylococcus aureus (n=4), Escherichia coli (n=2), Enterobacter cloacae (n=2), Pseudomonas aeruginosa (n=2) and Acinetobacter baumannii (n=2). PCR revealed the presence of different sil genes on the extracted plasmids. Plasmid transformation resulted in the transfer of silver-resistance to the resulting transformants. The extracted plasmids had different replicon types. CONCLUSION: Plasmid-mediated silver-resistance was detected for the first time, in clinical P. aeruginosa, A. baumannii and S. aureus isolates; in addition to its detection in K. pneumoniae, E. coli and Enterobacter cloacae. Therefore, strict monitoring on the use of silver compounds in medical settings is required; with implementation of an approved standardized method for silver-resistance detection. |
format | Online Article Text |
id | pubmed-6636436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-66364362019-08-01 The increasing threat of silver-resistance in clinical isolates from wounds and burns Hosny, Alaa El-Dien MS Rasmy, Salwa A Aboul-Magd, Dina S Kashef, Mona T El-Bazza, Zeinab E Infect Drug Resist Original Research PURPOSE: The widespread use of silver-containing compounds has led to emergence of silver-resistant bacteria. Few studies are available on the detectability of plasmid-mediated silver-resistance in developing countries. Therefore, we aimed to detect silver-resistance in isolates from wounds and burns, and to genetically characterize plasmid-mediated silver-resistance genes (sil genes). METHODS: One hundred and fifty clinical isolates were obtained from burns and wounds. They were identified using the suitable Analytical Profile Index and MicroScan identification systems. Their antimicrobial susceptibility was tested by the disk diffusion and broth microdilution methods. Their silver nitrate (AgNO(3)) minimum inhibitory concentration (MIC) was determined using the broth macrodilution method. The presence of different sil genes on plasmids extracted from silver-resistant isolates and the replicon types of the extracted plasmids were investigated using polymerase chain reaction (PCR). The ability of these plasmids to impart silver-resistance was tested by transformation. RESULTS: All except two isolates were multidrug-resistant. Nineteen silver-resistant bacterial isolates (12.6%) were detected; with AgNO(3) MIC ≥512 µg/mL. They were identified as Klebsiella pneumoniae (n=7), Staphylococcus aureus (n=4), Escherichia coli (n=2), Enterobacter cloacae (n=2), Pseudomonas aeruginosa (n=2) and Acinetobacter baumannii (n=2). PCR revealed the presence of different sil genes on the extracted plasmids. Plasmid transformation resulted in the transfer of silver-resistance to the resulting transformants. The extracted plasmids had different replicon types. CONCLUSION: Plasmid-mediated silver-resistance was detected for the first time, in clinical P. aeruginosa, A. baumannii and S. aureus isolates; in addition to its detection in K. pneumoniae, E. coli and Enterobacter cloacae. Therefore, strict monitoring on the use of silver compounds in medical settings is required; with implementation of an approved standardized method for silver-resistance detection. Dove 2019-07-08 /pmc/articles/PMC6636436/ /pubmed/31372006 http://dx.doi.org/10.2147/IDR.S209881 Text en © 2019 Hosny et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Hosny, Alaa El-Dien MS Rasmy, Salwa A Aboul-Magd, Dina S Kashef, Mona T El-Bazza, Zeinab E The increasing threat of silver-resistance in clinical isolates from wounds and burns |
title | The increasing threat of silver-resistance in clinical isolates from wounds and burns |
title_full | The increasing threat of silver-resistance in clinical isolates from wounds and burns |
title_fullStr | The increasing threat of silver-resistance in clinical isolates from wounds and burns |
title_full_unstemmed | The increasing threat of silver-resistance in clinical isolates from wounds and burns |
title_short | The increasing threat of silver-resistance in clinical isolates from wounds and burns |
title_sort | increasing threat of silver-resistance in clinical isolates from wounds and burns |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636436/ https://www.ncbi.nlm.nih.gov/pubmed/31372006 http://dx.doi.org/10.2147/IDR.S209881 |
work_keys_str_mv | AT hosnyalaaeldienms theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns AT rasmysalwaa theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns AT aboulmagddinas theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns AT kashefmonat theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns AT elbazzazeinabe theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns AT hosnyalaaeldienms increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns AT rasmysalwaa increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns AT aboulmagddinas increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns AT kashefmonat increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns AT elbazzazeinabe increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns |